Table of Contents Author Guidelines Submit a Manuscript
Journal of Chemistry
Volume 2014, Article ID 897141, 7 pages
http://dx.doi.org/10.1155/2014/897141
Research Article

Synthesis of New [1,2,4]Triazolo[3,4-b][1,3,4]thiadiazines and Study of Their Anti-Candidal and Cytotoxic Activities

1Department of Pharmaceutical Chemistry, College of Pharmacy, King Saud University, P.O. Box 2457, Riyadh 11451, Saudi Arabia
2Department of Pharmaceutics, College of Pharmacy, King Saud University, P.O. Box 2457, Riyadh 11451, Saudi Arabia
3Stem Cell & Tissue Re-Engineering Program, Research Center, King Faisal Specialized Hospital & Research Center, MBC-03, P. O. Box 3354, Riyadh 11211, Saudi Arabia

Received 9 April 2014; Revised 21 May 2014; Accepted 26 May 2014; Published 18 June 2014

Academic Editor: Xinyong Liu

Copyright © 2014 Mashooq Ahmad Bhat et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. P. Eggimann, J. Garbino, and D. Pittet, “Epidemiology of Candida species infections in critically ill non-immunosuppressed patients,” The Lancet Infectious Diseases, vol. 3, no. 11, pp. 685–702, 2003. View at Publisher · View at Google Scholar · View at Scopus
  2. D. A. Enoch, H. A. Ludlam, and N. M. Brown, “Invasive fungal infections: a review of epidemiology and management options,” Journal of Medical Microbiology, vol. 55, no. 7, pp. 809–818, 2006. View at Publisher · View at Google Scholar · View at Scopus
  3. J. A. Maertens, “History of the development of azole derivatives,” Clinical Microbiology and Infection, vol. 10, no. 1, pp. 1–10, 2004. View at Google Scholar · View at Scopus
  4. D. Secci, B. Bizzari, A. Bolasco et al., “Synthesis, anti-Candida activity, and cytotoxicity of new (4-(4-iodophenyl)thiazol-2-yl)hydrazine derivatives,” European Journal of Medicinal Chemistry, vol. 53, pp. 246–253, 2012. View at Publisher · View at Google Scholar · View at Scopus
  5. W. M. Alarif, S. S. Al-Lihaibi, S. N. Ayyad, M. H. Abdel-Rhman, and F. A. Badria, “Laurene-type sesquiterpenes from the Red Sea red alga Laurencia obtusa as potential antitumor-antimicrobial agents,” European Journal of Medicinal Chemistry, vol. 55, pp. 462–466, 2012. View at Publisher · View at Google Scholar · View at Scopus
  6. A. Foroumadi, S. Mansouri, Z. Kiani, and A. Rahmani, “Synthesis and in vitro antibacterial evaluation of N-[5-(5-nitro-2-thienyl)-1,3,4-thiadiazole-2-yl] piperazinyl quinolones,” European Journal of Medicinal Chemistry, vol. 38, no. 9, pp. 851–854, 2003. View at Publisher · View at Google Scholar · View at Scopus
  7. S. Rollas, N. Kalyoncuoglu, D. Sur-Altiner, and Y. Yegenoglu, “5-(4-Aminophenyl)-4-substituted-2,4-dihydro-3H-1,2,4-triazole-3-thiones: synthesis and antibacterial and antifungal activities,” Pharmazie, vol. 48, no. 4, pp. 308–309, 1993. View at Google Scholar · View at Scopus
  8. I. Mir, M. T. Siddiqui, and A. Comrie, “Antituberculosis agents-I: á-[5-(2-Furyl)-1,2,4-triazol-3-ylthio] acethydrazide and related compounds,” Tetrahedron, vol. 26, no. 22, pp. 5235–5238, 1970. View at Google Scholar · View at Scopus
  9. B. S. Holla, B. Veerendra, M. K. Shivananda, and B. Poojary, “Synthesis characterization and anticancer activity studies on some Mannich bases derived from 1,2,4-triazoles,” European Journal of Medicinal Chemistry, vol. 38, no. 7-8, pp. 759–767, 2003. View at Publisher · View at Google Scholar · View at Scopus
  10. H. L. Yale and J. J. Piala, “Substituted s-triazoles and related compounds,” Journal of Medicinal Chemistry, vol. 9, no. 1, pp. 42–46, 1966. View at Google Scholar · View at Scopus
  11. M. Y. Mhasalkar, M. H. Shah, S. T. Nikam, K. G. Anantanarayanan, and C. V. Deliwala, “4-Alkyl-5-aryl-4H-1,2,4-triazole-3-thiols as hypoglycemic agents,” Journal of Medicinal Chemistry, vol. 13, no. 4, pp. 672–674, 1970. View at Google Scholar · View at Scopus
  12. O. V. Dyablo and A. F. Pozharskii, “Synthesis and properties of N-aminoazolinethiones and N-aminoazinethiones,” Chemistry of Heterocyclic Compounds, vol. 33, no. 9, pp. 1003–1027, 1997. View at Publisher · View at Google Scholar · View at Scopus
  13. I. A. Al-Masoudi, Y. A. Al-Soud, N. J. Al-Salihi, and N. A. Al-Masoudi, “1,2,4-triazoles: synthetic approaches and pharmacological importance. (Review),” Chemistry of Heterocyclic Compounds, vol. 42, no. 11, pp. 1377–1403, 2006. View at Publisher · View at Google Scholar · View at Scopus
  14. G. Turan-Zitouni, Z. A. Kaplancikli, K. Erol, and F. S. Kiliç, “Synthesis and analgesic activity of some triazoles and triazolothiadiazines,” IL Farmaco, vol. 54, no. 4, pp. 218–223, 1999. View at Publisher · View at Google Scholar · View at Scopus
  15. N. D. Heindel and J. R. Reid, “4-Amino-3-mercapto-4H-1,2,4-triazoles and propargyl aldehydes: a new route to 3-R-8-aryl-1,2,4-triazolo[3,4-b]1,3,4-thiadiazepines,” Journal of Heterocyclic Chemistry, vol. 17, no. 5, pp. 1087–1088, 1980. View at Google Scholar · View at Scopus
  16. T. Karabasanagouda, A. V. Adhikari, and N. S. Shetty, “Synthesis and antimicrobial activities of some novel 1,2,4-triazolo[3,4-b]-1,3,4-thiadiazoles and 1,2,4-triazolo[3,4-b]-1,3,4-thiadiazines carrying thioalkyl and sulphonyl phenoxy moieties,” European Journal of Medicinal Chemistry, vol. 42, no. 4, pp. 521–529, 2007. View at Publisher · View at Google Scholar · View at Scopus
  17. M. Bhalla, A. Hitkari, V. R. Gujrati, T. N. Bhalla, and K. Shanker, “Benzopyran-2-one derivatives: antiinflammatory, analgesic and antiproteolytic agents,” European Journal of Medicinal Chemistry, vol. 29, no. 9, pp. 713–717, 1994. View at Publisher · View at Google Scholar · View at Scopus
  18. S. A. Khanum, S. Shashikanth, S. Umesha, and R. Kavitha, “Synthesis and antimicrobial study of novel heterocyclic compounds from hydroxybenzophenones,” European Journal of Medicinal Chemistry, vol. 40, no. 11, pp. 1156–1162, 2005. View at Publisher · View at Google Scholar · View at Scopus
  19. Z. A. Kaplancikli, G. Turan-Zitouni, A. Özdemir, and G. Revial, “New triazole and triazolothiadiazine derivatives as possible antimicrobial agents,” European Journal of Medicinal Chemistry, vol. 43, no. 1, pp. 155–159, 2008. View at Publisher · View at Google Scholar · View at Scopus
  20. B. S. Holla, B. S. Rao, B. K. Sarojini, P. M. Akberali, and N. S. Kumari, “Synthesis and studies on some new fluorine containing triazolothiadiazines as possible antibacterial, antifungal and anticancer agents,” European Journal of Medicinal Chemistry, vol. 41, no. 5, pp. 657–663, 2006. View at Publisher · View at Google Scholar · View at Scopus
  21. P. Karegoudar, D. J. Prasad, M. Ashok, M. Mahalinga, B. Poojary, and B. S. Holla, “Synthesis, antimicrobial and anti-inflammatory activities of some 1,2,4-triazolo[3,4-b][1,3,4]thiadiazoles and 1,2,4-triazolo[3,4-b][1,3,4]thiadiazines bearing trichlorophenyl moiety,” European Journal of Medicinal Chemistry, vol. 43, no. 4, pp. 808–815, 2008. View at Publisher · View at Google Scholar · View at Scopus
  22. G. L. Almajan, S. F. Barbuceanu, L. Saramet, and C. Draghici, “New 6-amino-[1,2,4]triazolo[3,4-b][1,3,4]thiadiazines and [1,2,4]triazolo[3,4-b] [1,3,4]thiadiazin-6-ones: synthesis, characterization and antibacterial activity evaluation,” European Journal of Medicinal Chemistry, vol. 45, no. 7, pp. 3191–3195, 2010. View at Publisher · View at Google Scholar · View at Scopus
  23. S. M. I. Badr and R. M. Barwa, “Synthesis of some new [1,2,4]triazolo[3,4-b][1,3,4]thiadiazines and [1,2,4]triazolo[3,4-b][1,3,4] thiadiazoles starting from 5-nitro-2-furoic acid and evaluation of their antimicrobial activity,” Bioorganic & Medicinal Chemistry, vol. 19, no. 15, pp. 4506–4512, 2011. View at Publisher · View at Google Scholar · View at Scopus
  24. O. Prakash, D. K. Aneja, K. Hussain et al., “Synthesis and biological evaluation of dihydroindeno and indeno [1,2-e] [1,2,4]triazolo [3,4-b] [1,3,4]thiadiazines as antimicrobial agents,” European Journal of Medicinal Chemistry, vol. 46, no. 10, pp. 5065–5073, 2011. View at Publisher · View at Google Scholar · View at Scopus
  25. M. Duan, W. M. Kazmierski, P. Y. Chong et al., “Discovery of novel pyridyl carboxamides as potent CCR5 antagonists and optimization of their pharmacokinetic profile in rats,” Bioorganic & Medicinal Chemistry Letters, vol. 21, no. 21, pp. 6470–6475, 2011. View at Publisher · View at Google Scholar · View at Scopus
  26. G. R. Luedtke, K. Schinzel, X. Tan et al., “Amide-based inhibitors of p38α MAP kinase. Part 1: discovery of novel N-pyridyl amide lead molecules,” Bioorganic & Medicinal Chemistry Letters, vol. 20, no. 8, pp. 2556–2559, 2010. View at Publisher · View at Google Scholar · View at Scopus
  27. M. Packiarajan, H. Coate, M. Desai et al., “5-(2′-Pyridyl)-2-aminothiazoles: alkyl amino sulfonamides and sulfamides as potent NPY5 antagonists,” Bioorganic & Medicinal Chemistry Letters, vol. 21, no. 21, pp. 6500–6504, 2011. View at Publisher · View at Google Scholar · View at Scopus
  28. A. K. Chhillar, P. Arya, C. Mukherjee et al., “Microwave-assisted synthesis of antimicrobial dihydropyridines and tetrahydropyrimidin-2-ones: novel compounds against aspergillosis,” Bioorganic & Medicinal Chemistry, vol. 14, no. 4, pp. 973–981, 2006. View at Publisher · View at Google Scholar · View at Scopus
  29. M. A. Bhat, A. A. Khan, S. Khan, M. A. Al-Omar, M. K. Parvez, and M. S. Al-Dosari, “Synthesis and anti-Candidal activity of N-(4-aryl/cyclohexyl)-2-(pyridine-4-yl-carbonyl) hydrazinecarbothioamide,” Bioorganic & Medicinal Chemistry Letters, vol. 24, no. 5, pp. 1299–1302, 2014. View at Publisher · View at Google Scholar
  30. V. R. Solomon, C. Hu, and H. Lee, “Hybrid pharmacophore design and synthesis of isatin-benzothiazole analogs for their anti-breast cancer activity,” Bioorganic & Medicinal Chemistry, vol. 17, no. 21, pp. 7585–7592, 2009. View at Publisher · View at Google Scholar · View at Scopus
  31. S. J. Gilani, S. A. Khan, O. Alam, and N. Siddiqui, “Synthesis and in vitro antimicrobial evaluation of condensed heterocyclic 6-substituted 1,2,4-triazolo-[3,4-b]-1,3,4-thiadiazole and 1,3,4-oxadiazole derivatives of isoniazid,” Acta Poloniae Pharmaceutica, vol. 68, no. 2, pp. 205–211, 2011. View at Google Scholar · View at Scopus
  32. B. F. Abdel-Wahab, H. A. Abdel-Aziz, and E. M. Ahmed, “Synthesis and antimicrobial evaluation of some 1,3-thiazole, 1,3,4-thiadiazole, 1,2,4-triazole, and 1,2,4-triazolo[3,4-b][1,3,4]-thiadiazine derivatives including a 5-(benzofuran-2-yl)-1-phenylpyrazole moiety,” Monatshefte für Chemie, vol. 140, no. 6, pp. 601–605, 2009. View at Publisher · View at Google Scholar · View at Scopus
  33. H. K. Fun, S. Chantrapromma, M. A. Bhat, and H. A. Abdel-Aziz, “(Z)-7-[2-(4-bromophenyl)hydrazin-1-yl-idene]-6-methyl-3-(pyridin-4-yl)-7H-1,2,4-triazolo[3,4-b][1,3,4]thiadiazine,” Acta Crystallographica E, vol. 68, no. 5, pp. o1512–o1513, 2012. View at Publisher · View at Google Scholar · View at Scopus
  34. I. Khan, S. Zaib, A. Ibrar, N. H. Rama, J. Simpson, and J. Iqbal, “Synthesis, crystal structure and biological evaluation of some novel 1, 2, 4-triazolo[3, 4-b]-1, 3, 4-thiadiazoles and 1, 2, 4-triazolo[3, 4-b]-1, 3, 4-thiadiazines,” European Journal of Medicinal Chemistry, vol. 78, pp. 167–177, 2014. View at Publisher · View at Google Scholar
  35. P. Puthiyapurayil, B. Poojary, C. Chikkanna, and S. K. Buridipad, “Synthesis, spectral characterization and biological evaluation of a novel series of 6-arylsubstituted-3-[2-(4-substitutedphenyl)propan-2-yl]-7H-[1,2,4]triazolo[3,4-b][1,3,4]thiadiazines,” European Journal of Medicinal Chemistry, vol. 57, pp. 407–416, 2012. View at Publisher · View at Google Scholar · View at Scopus
  36. CLSI: Clinical Laboratory Standards Institute, “Performance standards for antimicrobial susceptibility testing,” Reference Method of Broth Dilution Antifungal Susceptibility Testing of Yeasts M27-A3, Clinical and laboratory Standards Institute, Wayne, Ind, USA, 2008. View at Google Scholar
  37. M. D. Altintop, Z. A. Kaplancıklıa, G. Turan-Zitouni et al., “Synthesis and anticandidal activity of new triazolothiadiazine derivatives,” European Journal of Medicinal Chemistry, vol. 46, no. 11, pp. 5562–5566, 2011. View at Publisher · View at Google Scholar · View at Scopus
  38. Y. Ozawa, N. H. Sugi, T. Nagasu et al., “E7070, a novel sulphonamide agent with potent antitumour activity in vitro and in vivo,” European Journal of Cancer, vol. 37, no. 17, pp. 2275–2282, 2001. View at Publisher · View at Google Scholar · View at Scopus